97-22420. Notice of Listing of Members of the Food and Drug Administration's Senior Executive Service Performance Review Board

[Federal Register Volume 62, Number 164 (Monday, August 25, 1997)]
[Notices]
[Page 44976]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-22420]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Notice of Listing of Members of the Food and Drug 
Administration's Senior Executive Service Performance Review Board

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) announces the persons 
who will serve on the FDA Performance Review Board (PRB). This action 
is being taken in accordance with Title 5 U.S.C. 4314(c)(4), which 
requires that members of performance review boards be appointed in a 
manner to ensure consistency, stability, and objectivity in performance 
appraisals, and requires that notice of the appointment of an 
individual to serve as a member be published in the Federal Register.

FOR FURTHER INFORMATION CONTACT: Arlene S. Karr, Office of Human 
Resources and Management Services (HFA-408), Food and Drug 
Administration, 5600 Fishers Lane, rm. 7B-32, Rockville, MD 20857, 301-
827-4183.
The following persons will serve on the FDA PRB, which oversees the 
evaluation of performance appraisals of FDA's Senior Executive Service 
(SES) members:
Michael A. Friedman, M.D., Chairperson
Robert J. Byrd
Margaret J. Porter
Sharon Smith Holston
Mary K. Pendergast
William B. Schultz

    Dated: August 14, 1997.
Michael A. Friedman,
Lead Deputy Commissioner for the Food and Drug Administration.
[FR Doc. 97-22420 Filed 8-22-97; 8:45 am]
BILLING CODE 4160-01-F